As one of the largest Clinical Research Organizations in the world, we have recently brought to life four ultramodern Clinical Research Units in the UK and US... and the jewel in the crown is our facility at Drapers Yard Leeds.
What if your telephone skills are what we need to make new medicines safer for patients?
A brand new, world class, state-of-the-art 65,000 ft clinic with 100 beds, fully dedicated to Phase I Clinical research (and 7 minutes walking from the train station!)
SRG are working with a Global Biopharmaceutical company to help them find a Research Associate to join their busy team.
We are seeking a highly motivated Research Associate with experience using tissue culture and performing protein or cell-based assays, preferably in an industry setting.
You will be responsible for performing protein and cell-based screening assays for small molecules, biologics and new therapeutic modalities.
As one of the largest Clinical Research Organizations in the world, we have recently brought to life four ultramodern Clinical Research Units in the UK and US... and the jewel in the crown is our facility at Drapers Yard Leeds.
A brand new, world class, state-of-the-art 65,000 ft clinic with 100 beds (and growing), fully dedicated to Phase I Clinical research (and 7 minutes walking from the train station!)
We are now seeking our next GP Reports Administrator.
As one of the largest Clinical Research Organizations in the world, we have recently brought to life four ultra-modern Clinical Research Units in the UK and US... and the jewel in the crown is our facility at Drapers Yard Leeds.
A brand new, world class, state-of-the-art 65,000 ft clinic with 100 beds (and growing), fully dedicated to Phase I Clinical research (and 7 minutes walking from the train station!)
This is where you come in because we are now expanding our team of Technicians.
Position Overview: Reed are proud to be working a leading institution in clinical research in their search for junior doctors to assist in a clinical trial.
The trial seeks to investigate the effect of oral semaglutide vs. placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Participants take part remotely (by completing questionnaires on their own device or during telephone interviews with research nurses) and study treatment is sent to their homes by post.
About the Trial: Our Client is conducting a significant clinical trial to investigate the effects of oral semaglutide versus placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Study treatments will be sent to participants' homes by post.
Participants will take part remotely by completing questionnaires on their own devices or during telephone interviews with research nurses.
Brain Tumour Research is looking for a Community Fundraiser to provide support, and to help our donors and supporters fundraise, building connections to ensure a lifetime relationship between the charity and individual.
Position: Community Fundraiser - Scotland
Benefits: Holiday entitlement, 25 days per annum, excluding UK Public Holidays, access to a Employee Assistance Programme and option to join our healthcare scheme.
As one of the world's largest Clinical Research Organizations, Fortrea operates four ultramodern Clinical Research Units in the UK and US.
Our crown jewel is Drapers Yard in Leedsa brand-new, state-of-the-art 65,000 ft clinic with 100 beds, fully dedicated to Phase I clinical research, just a 7-minute walk from the train station!
Have you ever thought that your scheduling skills could save lives?
The database is held within the NHS and managed by the UK Haemophilia Centre Doctors' Organisation (UKHCDO) which is an association of medical practitioners who work within the NHS Haemophilia Centre's of England, Scotland, Northern Ireland, or Wales and have an interest in the care of people with Haemophilia or other inherited bleeding disorders.
The (NHD) is a register of people in the UK with all types of bleeding disorders started in 1969.
Its purpose is to study the complete national cohort of patients with these conditions and improve the care of people with bleeding disorders.